Items where Author is "Emery, S."
Jump to: 2008 Number of items: 4. 2008Strategies, for Management of Antiretroviral Therapy Study Group and Lundgren, J. D. and Babiker, A. and El-Sadr, W. and Emery, S. and Grund, B. and Neaton, J. D. and Neuhaus, J. and Phillips, A. N.. (2008) Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study : role of CD4+ Cell counts and HIV RNA levels during follow-up. Journal of infectious diseases, Vol. 197, no. 8. pp. 1145-1155. Strategies, for Management of Antiretroviral Therapy Study Group and Emery, S. and Neuhaus, J. A. and Phillips, A. N. and Babiker, A. and Cohen, C. J. and Gatell, J. M. and Girard, P. M. and Grund, B. and Law, M. and Losso, M. H. and Palfreeman, A. and Wood, R.. (2008) Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. Journal of infectious diseases, Vol. 197, no. 8. pp. 1133-1144. Smart, Study Group and El-Sadr, W. M. and Grund, B. and Neuhaus, J. and Babiker, A. and Cohen, C. J. and Darbyshire, J. and Emery, S. and Lundgren, J. D. and Phillips, A. and Neaton, J. D.. (2008) Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Annals of internal medicine, Vol. 149, H. 5. pp. 289-299. Fox, Z. and Phillips, A. and Cohen, C. and Neuhaus, J. and Baxter, J. and Emery, S. and Hirschel, B. and Hullsiek, K. H. and Stephan, C. and Lundgren, J. and Smart, Study Group. (2008) Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS, Vol. 22. pp. 2279-2289. |
